AMP-activated protein kinase: the guardian of cardiac energy status.
Hardie
D Grahame
DG
Division of Molecular Physiology, Faculty of Life Sciences, Wellcome Trust Biocentre, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, UK. d.g.hardie@dundee.ac.uk
D055372:AMP-Activated Protein Kinases; D000620:Aminoimidazole Carboxamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D017209:Apoptosis / Q000235:genetics; D004734:Energy Metabolism; D004789:Enzyme Activation / Q000235:genetics; D006801:Humans; D008954:Models, Biological; D009097:Multienzyme Complexes / Q000235:genetics / Q000378:metabolism*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D009336:Necrosis; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D012263:Ribonucleosides / Q000627:therapeutic use; D015534:Trans-Activators / Q000627:therapeutic use
D009097:Multienzyme Complexes; D012263:Ribonucleosides; D015534:Trans-Activators; D000620:Aminoimidazole Carboxamide; C011651:acadesine; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases